Search results

Being discharged from the hospital after illness or surgery is only the beginning of recovery. As with many infrequently-spoken moments in healthcare, COVID-19 has revealed the long road to recovery for "long-haulers," those whose symptoms linger for months. As a new study reports, this isn’t a new finding specific to the virus. (Of course, any experienced physician might have told you that already.)

Nationally, according to The American Farm Bureau Federation, farm and ranch families comprise less than 2% of the U.S. population, growing and producing the food for what the other 98% need. The rest of us are free to choose other livelihoods. This results in most consumers having limited to no understanding regarding standard agricultural practices, basic plant physiology, and the global food challenge to feed over 7 billion people.

Is President Trump, Rudy Giuliani, or any other individual infected with COVID-19 susceptible to reinfection? While there are a few scattered reports, the real question is how much of our immune response persists. A new study provides updated information.

COVID-19 infections are relentless. In every state, November rates increased over October, more than doubling on average. And these rates are widely dispersed across the nation. Early COVID-19 cases and deaths were associated with local conditions, including residential crowding and household income. More personal factors have since come into play as the pandemic spread and hotspots shifted to the heartland.

Inoculations are a welcome development, but the public should temper its excitement.

Those who favor indefinite lockdowns believe they have the moral high ground. They do not. In reality, they callously turn a blind eye to the economic and social devastation that their policy is causing.

Like Dracula rising again from the grave, there's been another round of articles suggesting that based on death counts COVID-19 is not a problem. It's time to try, once again, to put a stake into this misbelief and misunderstanding.

The latest polling by the Pew Research Center shows that 60% of Americans are willing to get vaccinated to guard against COVID-19. That's based on a representative sample of Americans polled after the announcements by both Pfizer and Moderna. Here's a breakdown of who's willing to line up, based upon some demographics.

The transformation of Hong Kong, less illuminated scientific pioneers, the many social distance circles, can you believe your lying eyes, and a mysterious ether holding the universe together - scientists call it dark matter.

From vaping to cutting-edge biotechnology, UK health regulators do a far better job than their American counterparts. This was proven yet again when the UK beat the U.S. FDA at approving a coronavirus vaccine produced by Pfizer, an American company.

Fear is a strong motivator; it is the basis of ‘Fight or Flight.” Long before the Florida business shutdown was declared, many self-anointed, at-risk individuals voluntarily stayed home. So what role does fear play in COVID-19 era? And specifically, to what degree is fear driving our behavior?

Reports of an H5N8 influenza virus spreading among birds across the globe understandably have generated concern. However, H5 viruses do not pose a direct threat to the health of the vast majority of humans on the planet, at least not yet.

We've finally had some amazing (and badly needed) news about COVID. Vaccines from Pfizer and Moderna are about 95 percent protective against COVID. But perhaps more importantly, according to interim analyses, Moderna's vaccine is 100% protective against severe COVID. This number is not only more impressive but may also be more clinically relevant.

The day before Thanksgiving, "[t]he US reported more than 2,100 deaths in a single day [and] things are projected to get worse," especially with the December holidays plus New Year's coming up. We've got a season of merry-making ahead of us – which used to include family travel, vacations, and partying – all behaviors associated with COVID-19- spread. Things were looking gloomy – until three vaccine manufacturers recently reported promising and exciting vaccine trial results, which should be ready by spring. If we can just hang on till then, we'll be OK …., that is, if we can motivate the vaccine-hesitant.

'Tis the Season. And while shopping has changed, what to get someone remains a problem for all of us. A new paper by the scientists of commerce, marketers, reminds us of what gives the greatest happiness.

People with lower levels of antibodies against mumps -- the second "M" in the MMR vaccine -- are likelier to have a severe case of COVID.

More than six months after the hype of repurposed COVID drugs, we have nothing. But this wasn't at all unexpected. Here's why.

Not literally, but figuratively. Journalism's rule of thumb is true; bad news sells, and courtesy of a new study, we have some numbers to back that claim up. What we don’t know is why we prefer the negative over the positive.

Eric Topol is a cardiologist working in translational medicine, innovation, at Scripps Clinic in San Diego. He is an active commentator in healthcare. Here is his Twitter thread on Operation Warp Speed along with the vaccine development timeline.

What is perchlorate? And is it dangerous?

Until a few moments ago, I, too, had been a victim of "tl,dr." In fact, I had the disease but did not know its name. Tl,dr is an acronym to “Too long, didn’t read.” Admit it, you have suffered from the same malady, but help is on the way.

Science and democracy, when museums were the source of scientific education, and what's the real deal with Prevagen?

Statistics and science aren't the same thing. Moreover, statisticians aren't fortune tellers, yet we continue to treat them as if they are. It's time to stop.

Nearly a year into the pandemic, can we begin to make some definitive statements about the transmission of COVID-19 between individuals, based on a patient’s symptoms or testing? A meta-analysis provides some answers. (Or at least it gets us into the ballpark.)

The infectious period for a COVID patient is thought to be 10-20 days, based on the severity of the disease. One patient, however, was shedding virus for 105 days and was infectious for 70 of them.